Intravenous drug-addicts: A high risk group for HBV, HDV and HCV infections
✍ Scribed by Glória, H.; Marinho, R.; Pedro, M.; Ramalho, F.; Moura, M.C.
- Book ID
- 123147780
- Publisher
- Elsevier Science
- Year
- 1990
- Tongue
- English
- Weight
- 122 KB
- Volume
- 11
- Category
- Article
- ISSN
- 0168-8278
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
The prevalence of HBV, HDV and HIV infection was studied in 288 imprisoned intravenous drug addicts (IVDA) and 329 controls. Commercially available radioimmunoassays for the detection of HBV and HDV serologic markers and enzyme-immunoassays for IgM anti-HBc and anti-HIV were used. Anti-HIV positive
P a t o l o g i a M e d f c a H I , I s t i t u t o di S c i e n z e M e d i c h e -V i a F. S f o r z a , 35 -20122 M i l a n o , I t a l y • \*\* I s t i t u t o df V i r o l o g i a . U n i v e r s i t & di M i l a n o • \*\* O s p e d a l e Civile -G a r d o n e V . T .
## Abstract Although intravenous drug users are a well‐known route of hepatitis C virus (HCV) and hepatitis B virus (HBV) transmission, there is no data on the prevalence of HBV and HCV infection among intravenous drug users in Korea. In order to describe the prevalence of HBV and HCV infection, an